Preservation and Expansion of Current Domestic Capacities for Laboratory-Based Testing and Manufacturing of Over-The-Counter (OTC) Rapid Antigen and Point-Of-Care (POC) Nucleic Acid Amplification Tests (NAATs)
Closed Pre-Solicitation Posted
- Solicitation number
- 75A50122N00017
- Agency
-
Substance Abuse and Mental Health Services Administration
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- Not on record
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
Notice text
The COVID-19 pandemic has demonstrated how important a robust and resilient public health industrial base is in ensuring the health and security of the United States. It also highlighted the need for critical public health industrial investments at a scale never seen before in the United States. The HHS is conducting market research from manufacturers on their expertise, capacities, challenges, and innovative best practices with various components of the supply chain.
Please refer to the attachment for further information.
Files
| File | Type | Posted |
|---|---|---|
| RFI for Test Manufacturing Capacity Preservation and Expansion - FINAL.docx | DOCX document |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity